Sig-1R agonists could decrease the proportion of Sig-1R multimers formed and induce lipid microdomain remodeling in the ER membrane, which might lead to an improvement in MAM function in neurons of Alzheimer’s disease and amyotrophic lateral sclerosis [37]. This evidence concerns the gene SIGMAR1 and amyotrophic lateral sclerosis.